Gilead risk analysis

Use Gilead Sciences Inc risk analysis concurrently with your other holdings, portfolios, and investing themes to protect against small markets fluctuations and to back test it against optimization strategy that fits your risk preferences.  Analyze Themes

Projected Return Density against Market

Given investment horizon of 30 days, the stock has beta cooficient of 2.17 . This indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are expected to be negative, Gilead will likely underperform. In addition to that, Gilead Sciences Inc has alpha of 2.17 implying that it can potentially generate 2.17% excess return over S&P 500 after adjusting for the inherited market risk (beta).Given investment horizon of 30 days, the coefficient of variation of Gilead is 481.51. The daily returns are destributed with a variance of 4.56 and standard deviation of 2.14. The mean deviation of Gilead Sciences Inc is currently at 1.7. For similar time horizon, the selected benchmark (S&P 500) has volatility of 0.57

	(alpha)	=	2.17	Details
	(beta)	=	2.17	Details
	(volatility)	=	2.14	Details

Actual Return Volatility

Gilead Sciences Inc inherits 2.14% risk (volatility on return distribution) over the 30 days horizon. S&P 500 shows 0.57% volatility of returns over 30 trading days.